• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
Abraxis Bioscience Inc. developed and delivered therapeutics and technologies for patients treatments for cancer and other critical illnesses.APP Pharmaceuticals is a global biopharmaceutical company, which develops, manufactures and markets injectable pharmaceutical products, primarily focused on the injectable oncology, anti-infective and critical care markets. Co. manufactures products in each of the three basic forms in which injectable products are sold: liquid, powder and lyophilized, or freeze-dried. Co.'s products are mainly used in hospitals, long-term care facilities, alternate care sites and clinics within North America. At Dec 31 2007, Co. manufactured and marketed 17 injectable oncology product families, 21 injectable anti-infective product families, and more than 60 injectable critical care product families.
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
No longer subject to file | 2008-09-10 | 0 | |
|
No longer subject to file | 2008-09-10 | 0 | |
|
THEMBA 2005 TRUST II |
|
No longer subject to file | 2008-09-10 | 0 |
|
THEMBA 2005 TRUST I |
|
No longer subject to file | 2008-09-10 | 0 |
|
MAROUN RICHARD E CHIEF ADMINISTRATIVE OFFICER |
|
No longer subject to file | 2008-09-10 | 0 |
|
SILBERG THOMAS CHIEF EXECUTIVE OFFICER & PRES |
|
No longer subject to file | 2008-09-10 | 0 |
|
HARMON J FRANK EXEC. VP AND COO |
|
No longer subject to file | 2008-09-10 | 0 |
|
No longer subject to file | 2008-09-10 | 0 | |
|
No longer subject to file | 2008-09-10 | 0 | |
|
No longer subject to file | 2008-09-10 | 0 | |
|
No longer subject to file | 2008-09-10 | 0 | |
|
TAJAK RICHARD J. EXEC. VP & CFO |
|
No longer subject to file | 2008-09-10 | 0 |
|
0 | 2007-12-19 | 0 | |
|
PAULI RONALD CHIEF FINANCIAL OFFICER |
|
0 | 2006-08-10 | 0 |
|
10,000 | 2006-08-01 | 0 | |
|
10,000 | 2006-08-01 | 0 | |
|
10,000 | 2006-08-01 | 0 | |
|
10,000 | 2006-08-01 | 0 | |
|
GOPALAKRISHNAN LISA EXECUTIVE VP |
|
0 | 2006-08-01 | 0 |
|
0 | 2006-08-01 | 0 | |
|
WILLIAMS NICOLE CHIEF FINANCIAL OFFICER |
|
0 | 2006-06-01 | 0 |
|
WENDEL BRUCE EXEC. VP CORPORATE DEVELOPMENT |
|
0 | 2006-05-24 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
